全球腰椎间盘突出症治疗市场 – 行业趋势及 2029 年预测

市场分析和规模

几乎 80% 的人口一生中至少会经历一次腰痛 (LBP)。由于腰痛发病率高且对残疾的影响巨大，美国每年为此花费超过 1000 亿美元。腰痛最常见的原因是椎间退化，导致退行性椎间盘疾病和腰椎间盘突出症 (LDH)。腰椎间盘突出症最常影响 L4-L5 和 L5-S1 水平，是腰痛和腿部不适的主要原因。

Data Bridge Market Research 分析称，2021 年腰椎间盘突出症治疗市场价值为 256.8 万美元，预计到 2029 年将达到 416 万美元，在 2022 年至 2029 年的预测期内复合年增长率为 6.20%。Data Bridge Market Research 团队策划的市场报告包括深入的专家分析、患者流行病学、管道分析、定价分析和监管框架。

报告范围和市场细分

Market Definition

Lumbar disc herniation (LDH) is a frequent low back condition. It's one of the most frequent disorders that causes low back and/or leg discomfort in people. A herniated disc occurs when disc material (nucleus pulposus or annulus fibrosis) is displaced outside the intervertebral disk's region. This herniation cycle begins with failure in the innermost annulus rings and moves radially outward. Damage to the annulus of the disc is commonly related with totally flexing the spine over an extended period of time.

Lumbar Disc Herniation Treatment Market Dynamics

Drivers

• High prevalence rate of smoking

The rise in prevalence rate of smoking will act as a major driver that will result in the expansion of the growth rate of the market. Smoking is thought to reduce the oxygen flow to discs, causing them to break down faster and hence will further cushion the growth rate of lumbar disc herniation treatment market.

• Sedentary lifestyle of people

The increasing prevalence of sedentary lifestyle among people such as lack of physical exercise is the major reason which is estimated to enhance the market’s growth rate during the forecast period of 2022-2029. Back problems are more common among people who work in physically demanding jobs. Lifting, pushing, twisting repeatedly, tugging, and bending laterally, can also lead to a herniated disc.

• Increasing investment for healthcare infrastructure

Another significant factor influencing the growth rate of lumbar disc herniation treatment market is the rising healthcare expenditure which helps in improving its infrastructure. Also, various government organizations aims to improve the healthcare infrastructure by increasing funding and this will further influence the market dynamics.

Furthermore, rising initiatives by public and private organizations to spread awareness will expand the lumbar disc herniation treatment market. Additionally, introduction and swift adoption related to the technologically advanced medical devices and surging geriatric population will result in the expansion of lumbar disc herniation treatment market.

 Opportunities

• Increase in the number of research and development activities       

Moreover, the market's growth is fueled by an increase in the number of research and development activities. This will provide beneficial opportunities for the lumbar disc herniation treatment market growth. Along with this, rising drug approvals and launches will further propel the market’s growth rate.

Moreover, rising investment for the development of advanced technologies and increase in the number of emerging markets will further provide beneficial opportunities for the lumbar disc herniation treatment market growth during the forecast period.

Restraints/Challenges

On the other hand, high cost associated with the treatment will obstruct the growth rate of market. The lack of healthcare infrastructure in developing economies and the dearth of skilled professionals will challenge the lumbar disc herniation treatment market. Additionally, strict food and drug administration (FDA) guidelines for approving new medication and lack of awareness about the treatment will act as restrain and further impede the growth rate of market during the forecast period of 2022-2029.

This lumbar disc herniation treatment market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the lumbar disc herniation treatment market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Patient Epidemiology Analysis

Lumbar disc herniation treatment market also provides you with detailed market analysis for patient analysis, prognosis and cures. Prevalence, incidence, mortality, adherence rates are some of the data variables that are available in the report. Direct or indirect impact analyses of epidemiology to market growth are analysed to create a more robust and cohort multivariate statistical model for forecasting the market in the growth period.

COVID-19 Impact on Lumbar Disc Herniation Treatment Market

During the COVID-19 outbreak, the patient's condition in both the spinal outpatient and emergency departments has reached a critical stage, with a level of seriousness well above normal. Individuals have experienced anxiety disorders as a result of the COVID 19 pandemic, which was exacerbated by the epidemic's loneliness. Excessive concern about their health, illness, and contracting the coronavirus has resulted in an increase in hospital visits. To combat these difficulties, governments are investing in infrastructure connected to slipped disc issues, as well as the development of the COVID 19 vaccine and treatment.

全球腰椎间盘突出症治疗市场范围

腰椎间盘突出症治疗市场根据类型、位置类型、治疗、诊断、剂型、给药途径、最终用户和分销渠道进行细分。这些细分市场之间的增长将帮助您分析行业中增长缓慢的细分市场，并为用户提供有价值的市场概览和市场洞察，帮助他们做出战略决策，确定核心市场应用。

位置类型

• 腋窝
• 椎间孔
• 后外侧
• 中央脱垂

诊断

• 神经测试
• 肌电图 (EMG)
• 神经传导研究
• 影像学检查
• 磁共振成像（MRI）
• 脊髓造影
• 计算机断层扫描 (CT) 扫描
• X 射线
• 其他的

治疗

• 药物
• 非甾体抗炎药 (NSAID)
• 阿片类药物
• 肌肉松弛剂
• 局部皮质类固醇注射（CSI）
• 外科手术
• 极外侧显微椎间盘切除术
• 椎板切开术和椎间盘切除术
• 物理治疗
• 其他的

类型

• 慢性的
• 急性

剂型

• 注射
• 平板电脑
• 其他的

给药途径

• 肠外
• 口服
• 其他的

最终用户

• 医院
• 专科诊所
• 家庭护理
• 其他的

分销渠道

• 医院药房
• 零售药店
• 网上药店
• 其他的

腰椎间盘突出症治疗市场区域分析/见解

对腰椎间盘突出症治疗市场进行了分析，并按国家、类型、地点类型、治疗、诊断、剂型、给药途径、最终用户和分销渠道提供了市场规模洞察和趋势。

腰椎间盘突出症治疗市场报告涵盖的国家包括北美洲的美国、加拿大和墨西哥、欧洲的德国、法国、英国、荷兰、瑞士、比利时、俄罗斯、意大利、西班牙、土耳其、欧洲其他地区、亚太地区 (APAC) 的中国、日本、印度、韩国、新加坡、马来西亚、澳大利亚、泰国、印度尼西亚、菲律宾、亚太地区 (APAC) 的其他地区、中东和非洲 (MEA) 的其他地区、南美洲的巴西、阿根廷和南美洲其他地区

北美在市场份额和市场收入方面占据腰椎间盘突出症治疗市场的主导地位，并将在预测期内继续保持主导地位。这是由于主要关键参与者的存在，而医疗保健支出的增加将进一步推动该地区市场的增长率。

由于该地区腰椎间盘突出症的患病率不断上升，预计亚太地区在 2022-2029 年的预测期内将实现增长。此外，医疗保健基础设施的发展和政府举措的不断增加将进一步推动该地区市场的增长率。

报告的国家部分还提供了影响单个市场因素和国内市场监管变化，这些因素和变化会影响市场的当前和未来趋势。下游和上游价值链分析、技术趋势和波特五力分析、案例研究等数据点是用于预测单个国家市场情景的一些指标。此外，在提供国家数据的预测分析时，还考虑了全球品牌的存在和可用性以及它们因来自本地和国内品牌的激烈或稀缺竞争而面临的挑战、国内关税和贸易路线的影响。   

竞争格局和腰椎间盘突出症治疗市场份额分析

腰椎间盘突出症治疗市场竞争格局提供了竞争对手的详细信息。详细信息包括公司概况、公司财务状况、收入、市场潜力、研发投资、新市场计划、全球影响力、生产基地和设施、生产能力、公司优势和劣势、产品发布、产品宽度和广度、应用主导地位。以上提供的数据点仅与公司对腰椎间盘突出症治疗市场的关注有关。

腰椎间盘突出症治疗市场的一些主要参与者包括：

• 辉瑞公司（美国）
• 葛兰素史克公司 (英国)
• 诺华公司（瑞士）
• Mylan NV（美国）
• Teva Pharmaceutical Industries Ltd.（以色列）
• 赛诺菲（法国）
• 勃林格殷格翰国际有限公司（德国）
• 阿斯利康（英国）
• 强生私人有限公司（美国）
• 默克公司（美国）
• F. Hoffmann-La Roche Ltd.（瑞士）
• 太阳制药工业有限公司 (印度)
• Aurobindo Pharma（印度）
• Zydus Cadila（印度）
• NuVasive, Inc.（美国）
• Globus Medical（美国）
• Zimmer Biomet（美国）
• 美敦力（爱尔兰）
• 史赛克（美国）
• Assertio Therapeutics, Inc.（美国） 

SKU-56397